Levoleucovorin Calcium
Based on 3 publication(s) in Google Scholar
Levoleucovorin Calcium (Calcium levofolinate) is the active form of calcium Folinic acid (HY-13664) and has anti-tumor effects. Levoleucovorin Calcium is also a potentiator of the anti-cancer toxicity of 5-Fluorouracil (HY-90006).
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 99.90%
- CAS No.: 80433-71-2
- Formule: C20H21CaN7O7
- Masse moléculaire:511.50
-
Stockage:
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
-
Solvant et solubilité
- Pureté et documentation
- Références
-
Help & FAQs
-
HY-90006
5-FluorouracilThymidylate Synthase Inhibitor -
HY-17371
OxaliplatinDNA Synthesis Inhibitor -
HY-10820
Pemetrexed -
HY-10446
PralatrexateDihydrofolate Reductasean Inhibitor -
HY-13664
Folinic acid calciumBiological Folic Acid -
HY-16562
IrinotecanTopoisomerase I Inhibitor -
HY-17383
Levomefolate calciumFolate Supplement -
HY-B0215
AcetylcysteineMucolytic Agent -
HY-B0016
CapecitabineDNA/RNA Synthesis Inhibitor -
HY-10331
RegorafenibMulti-kinase Inhibitor -
HY-13781
Pemetrexed disodium hemipenta hydrateAutophagy Inducer -
HY-P9905
CetuximabEGFR Inhibitor
Publications Citing Use of MedChemExpress (MCE) Levoleucovorin Calcium
More
Activité biologique
Description
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Crj:CD(SD)BR rats (5 weeks)[2]
-
Dosage:6, 20 or 60 mg/kg/day
-
Administration:i.v.; for 4 weeks (combined with 10 mg/kg/day 5-Fluorouracil)
-
Result:Decreased the RBC counts, increased extramedullary hematopoiesis and enhanced the suppression of lymphatic organs.
Induced the potentiation in the toxicity of 5-Fluorouracil appeared to be mainly immuno-suppression and myelosuppression, which were related to the anti-tumor activity of 5-Fluorouracil.
Essai clinique
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 80433-71-2
-
Appearance Solid
-
Masse moléculaire 511.50
-
Formule C20H21CaN7O7
-
Color White to yellow
-
SMILES
O=C1C2=C(NC[C@H](CNC3=CC=C(C(N[C@H](C([O-])=O)CCC([O-])=O)=O)C=C3)N2C=O)NC(N)=N1.[Ca+2]
-
Synonyms
Calcium levofolinate; CL307782
-
Structure Classification
-
Initial Source
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Publications (3)
-
Journal Impact Factor
-
Most Recent
-
Nat Commun
THBS1-producing tumor-infiltrating monocyte-like cells contribute to immunosuppression and metastasis in colorectal cancer. [Abstract]2023 Sep 25;14(1):5534. PMID: 37749092 -
Mol Cancer Ther
Mosperafenib, a novel paradox breaker BRAF inhibitor with potent preclinical activity in BRAF mutated colorectal cancer. [Abstract]2025 Dec 4. PMID: 41340484 -
J Mol Med (Berl)
2019 Aug;97(8):1183-1193. PMID: 31201471
Solvant et solubilité
In Vitro:
H2O : 7.69 mg/mL (15.03 mM; Need ultrasonic)
DMSO : < 1 mg/mL (insoluble or slightly soluble)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Pureté et documentation
-
Fiche technique (273 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Instruction de manipulation (2659 KB)
Références
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| H2O | 1 mM | 1.9550 mL | 9.7752 mL | 19.5503 mL | 48.8759 mL |
| 5 mM | 0.3910 mL | 1.9550 mL | 3.9101 mL | 9.7752 mL | |
| 10 mM | 0.1955 mL | 0.9775 mL | 1.9550 mL | 4.8876 mL | |
| 15 mM | 0.1303 mL | 0.6517 mL | 1.3034 mL | 3.2584 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Levoleucovorin Calcium Related Classifications
HY-13667 Related Classifications
Powered by Bioz